-
PNV (old CZD), some good new has come out but boy things are slow, companies sole focus in polynovo burn/wound dressing now - hence name change, trading around 8-10 cents. Hopefully 15 brings some action. May need cap raise?
ADO - now 10-12 cents, lots of talk no action. Waiting for the "big deal" to come through. Might be waiting a while/forever
-
Anyone watch ARNA soar over on the NYSE the other night? If your blockbuster obesity drug sales never eventuate, hey, just start new clinical trials on something else!
-
Had a friend sucked into that crazy game. A fave spruik pump and dump stock big time manipulation with" fresh Blood" (suckers in reverse). AVOID unless your'e an addict for wasting away or Casinos are your saviour, or U haven't walked the plank of ego driven loss.. yeah right!
-
Originally Posted by Joshuatree
Had a friend sucked into that crazy game. A fave spruik pump and dump stock big time manipulation with" fresh Blood" (suckers in reverse). AVOID unless your'e an addict for wasting away or Casinos are your saviour, or U haven't walked the plank of ego driven loss.. yeah right!
Could apply that to the vast majory of biotech! I stay away from what I don't know, and most biotech has pump and dump written all over it to boot! There are the exceptions, but I see at as riskier than tech but only slightly less so than leveraged foreign ETFs
-
i got some acr, which is kind of hanging there.. may go either way.. lol
-
Originally Posted by BFG
Could apply that to the vast majory of biotech! I stay away from what I don't know, and most biotech has pump and dump written all over it to boot! There are the exceptions, but I see at as riskier than tech but only slightly less so than leveraged foreign ETFs
I'd agree with that insofar as the "research" type stocks are concerned. But there's been some resounding successes in the wider "human science" sector over the years - CSL, RMD, FPH, Cochlear etc. I fluked a winner with a British based, Aust listed company by the name of Cortecs - and sold before I understood what the real risks were with this type of stock. Had the good fortune too to buy into Cellestis, after their TB test had been proven and accepted by the medical profession. Bought out by a big Swiss pharma so didn't have to make a decision to sell! Now aiming to keep my 100% record in this sector by steering clear - unless.......
-
Originally Posted by BFG
Could apply that to the vast majory of biotech! I stay away from what I don't know, and most biotech has pump and dump written all over it to boot! There are the exceptions, but I see at as riskier than tech but only slightly less so than leveraged foreign ETFs
Im not wishing you good luck with ARNA. Dissapointed you bought it up in fact
-
Originally Posted by Joshuatree
Im not wishing you good luck with ARNA. Dissapointed you bought it up in fact
I wouldn't touch ARNA, just followed its movements over the years. Have you been burned by it JT?
-
A friend did. Thanks for clarifying.
-
Novogen NRT on The ASX is a very int stock. I haven't got a bio stock at the mo(its usually NEU). NRT has potentially many streams of income.
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
|
|
Bookmarks